Comparative safety and healthcare expenditures associated with frontline therapy for chronic myeloid leukemia

被引：0
|
作者：
Cole, Ashley L. [1 ]
Muluneh, Benyam [2 ]
Lund, Jennifer [2 ]
Wood, William [2 ]
Lafata, Jennifer Elston [2 ]
Dusetzina, Stacie [2 ]
机构：
[1] Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
913
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [1] FRONTLINE THERAPY OF CHRONIC MYELOID LEUKEMIA (CML)
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2014, 38 : S1 - S1
  • [2] Debating Frontline Therapy in Chronic Myeloid Leukemia
    Bi, Xia
    Ramanathan, Sabarina
    Keiffer, Gina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase
    Haddad, Fadi G.
    Sasaki, Koji
    Nasr, Lewis
    Short, Nicholas J.
    Kadia, Tapan
    Dellasala, Sara
    Cortes, Jorge
    Nicolini, Franck E.
    Issa, Ghayas C.
    Jabbour, Elias
    Kantarjian, Hagop
    CANCER, 2024, 130 (19) : 3344 - 3352
  • [4] Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia
    Marin, David
    SEMINARS IN HEMATOLOGY, 2010, 47 (04) : 312 - 318
  • [5] The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
    Wolfe, Heather R.
    Rein, Lindsay A. M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 448 - 454
  • [6] The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
    Heather R. Wolfe
    Lindsay A. M. Rein
    Current Hematologic Malignancy Reports, 2021, 16 : 448 - 454
  • [7] Optimal frontline therapy of chronic myeloid leukemia today, and related musings
    Kantarjian, Hagop M.
    Begna, Kebede
    Jabbour, Elias J.
    Paul, Shilpa
    Welch, Mary Alma
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (10) : 1855 - 1861
  • [8] Ponatinib As Frontline Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Jain, Preetesh
    Kantarjian, Hagop M.
    Jabbour, Elias
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval
    Gachimova, Evguenia
    Ferrajoli, Alessandra
    Kornblau, Steven M.
    Ravandi, Farhad
    O'Brien, Susan
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
  • [9] Comparative study of safety and efficacy of imatinib mesylate therapy in pediatric and adult chronic myeloid leukemia
    Raizada, N.
    Sagar, T.
    Ramanan, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Frontline therapy in Chronic Lymphocytic Leukemia
    Arguello-Tomas, Miguel
    Albiol, Nil
    Moreno, Carol
    ACTA HAEMATOLOGICA, 2024, 147 (01) : 49 - 61
12345